Multidrug-resistant gram-negative infections in transplant and oncology patients

Mehreen Arshad, Andrew Nowalk, Pranita D. Tamma

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

2 Citations (Scopus)


Multidrug-resistant gram-negative infections cause significant mortality and morbidity in the transplant and oncology patient population. Prolonged hospitalization and prior exposure to broad-spectrum antibiotics are common risk factors. Prevention strategies include daily bathing with chlorhexidine gluconate and use of isolation precautions. Recent data suggest that carbapenems provide adequate empiric therapy for most patients. However, culture data should be closely monitored to avoid overuse of broad-spectrum therapy.

Original languageEnglish
Title of host publicationPediatric Transplant and Oncology Infectious Diseases
ISBN (Electronic)9780323641982
Publication statusPublished - 1 Jan 2020
Externally publishedYes


  • Epidemiology
  • Gram-negatives
  • Immunocompromised
  • Multidrug-resistance
  • Prevention
  • Treatment


Dive into the research topics of 'Multidrug-resistant gram-negative infections in transplant and oncology patients'. Together they form a unique fingerprint.

Cite this